Clinical approach and current therapeutic management of Meibomian gland dysfunction
DOI:
https://doi.org/10.33936/qkrcs.v6i3.4668Keywords:
glándulas de Meibomio, síndromes de ojo seco, segmento anterior del ojo, Demodex folliculorum, blefaritisAbstract
In optometric clinical practice, it is essential to carry out a complete examination, since it is the discipline in charge of primary eye care and its exercise includes preventing, diagnosing and treating pathologies of the anterior segment. A very common pathology is Meibomian gland dysfunction (MGD), characterized by the obstruction of the glandular orifices, causing changes in glandular secretion, instability of the tear film, inflammation of the eyelids and damage to the ocular surface. prevalence of meibomian gland dysfunction is higher in Asian populations in contrast to the prevalence in Caucasians. It has been correlated with evaporative dry eye disease and the Demodex mite. The diagnosis of (MGD) goes from the most basic, and focuses on the evaluation of the eyelids and eyelashes in biomicroscopy. The therapeutic alternatives seek to improve the flow of glandular secretion through medications, ultrasonic stimulation, thermal pulsation, intraductal probing, among others. There is extensive bibliography on the (DGM); however, this narrative review compiled reliable information and related it to each other, allowing the efficiency of the diagnostic and therapeutic alternatives that currently exist to be compared.
Downloads
References
1. Altamirano JB, Villavicencio GA, Granja GA, Estévez DA. Disfunción de las glándulas de Meibomio. RECIAMUC [Internet]. 2020;4(4):4-13. Disponible en: https://doi.org/10.26820/reciamuc/4.(4).diciembre.2020.4-13
2. López-Ponce D, Zuazo F, Cartes C, Salinas-Toro D, Pérez-Valenzuela C, Valenzuela F, et al. Alta prevalencia de infestación por Demodex spp. en pacientes con blefaritis posterior: correlación con edad y caspa cilíndrica. Archivos de la Sociedad Española de Oftalmología [Internet]. 2017;92:412-8. Disponible en: https://doi.org/10.1016/j.oftal.2017.01.001
3. Sabeti S, Kheirkhah A, Yin J, Dana R. Management of meibomian gland dysfunction: a review. Survey of Ophthalmology [Internet]. 2020;65:205-17. Disponible en: https://doi.org/10.1016/j.survophthal.2019.08.007
4. Lu G, Gollapudi S, Li R, Pfeiffer ML, Mehta P, Jiang L, et al. Focused ultrasound stimulation on meibomian glands for the treatment of evaporative dry eye. Experimental Biology and Medicine [Internet]. 2022;247:519-26. Disponible en: https://doi.org/10.1177/15353702211052035
5. Nichols KK, Foulks GN, Bron AJ, Glasgow BJ, Dogru M, Tsubota K, et al. The international workshop on meibomian gland dysfunction: Executive summary. Investigative Ophthalmology and Visual Science [Internet]. 2011;52:1922-9. Disponible en: https://doi.org/10.1167/iovs.10-6997a
6. Nelson JD, Craig JP, Akpek EK, Azar DT, Belmonte C, Bron AJ, et al. TFOS DEWS II Introduction. Ocular Surface [Internet]. 2017;15:269-75. Disponible en: https://doi.org/10.1016/j.jtos.2017.05.005
7. Kim HM, Eom Y, Song JS. The Relationship Between Morphology and Function of the Meibomian Glands. Eye & Contact Lens: Science & Clinical Practice [Internet]. 2018;44:1-5. Disponible en: https://doi.org/10.1097/ICL.0000000000000336
8. Messmer EM. The Pathophysiology, Diagnosis, and Treatment of Dry Eye Disease. Deutsches Ärzteblatt International [Internet]. 2015. Disponible en: https://doi.org/10.3238/arztebl.2015.0071
9. Von Ahrentschildt A, Hanenberg L, Robich ML, Jones-Jordan LA, Marx S, Sickenberger W, et al. Morphological characteristics of Meibomian Glands and their Influence on Dry Eye disease in contact lens wearers. The Ocular Surface [Internet]. 2022;24:93-9. Disponible en: https://doi.org/10.1016/j.jtos.2022.01.002
10. Schanzlin D, Owen JP, Klein S, Yeh TN, Merchea MM, Bullimore MA. Efficacy of the Systane iLux Thermal Pulsation System for the Treatment of Meibomian Gland Dysfunction After 1 Week and 1 Month: A Prospective Study. Eye & Contact Lens: Science & Clinical Practice [Internet]. 2022;48:155-61. Disponible en: https://doi.org/10.1097/ICL.0000000000000847
11. Ha M, Kim JS, Hong S-Y, Chang D-J, Whang W-J, Na K-S, et al. Relationship between eyelid margin irregularity and meibomian gland dropout. The Ocular Surface [Internet]. 2021;19:31-7. Disponible en: https://doi.org/10.1016/j.jtos.2020.11.007
12. AlDarrab A, Alrajeh M, Alsuhaibani AH. Meibography for eyes with posterior blepharitis. Saudi Journal of Ophthalmology [Internet]. 2017;31:131-4. Disponible en: https://doi.org/10.1016/j.sjopt.2017.05.014
13. Ma X, Lu Y. Efficacy of Intraductal Meibomian Gland Probing on Tear Function in Patients With Obstructive Meibomian Gland Dysfunction. Cornea [Internet]. 2016;35:725-30. Disponible en: https://doi.org/10.1097/ICO.0000000000000777
14. Zhang L, Su Z, Zhang Z. Effects of Azithromycin on Gene Expression Profiles of Proinflammatory and Anti-inflammatory Mediators in the Eyelid Margin and Conjunctiva of Patients With Meibomian Gland Disease.en.es n.d. JAMA Ophthalmol [Internet]. 2015;133(10):1117-23. Disponible en: https://doi.org/10.1001/jamaophthalmol.2015.2326
15. Liu Y, Kam WR, Ding J, Sullivan DA. One man’s poison is another man’s meat: Using azithromycin-induced phospholipidosis to promote ocular surface health. Toxicology [Internet]. 2015;320:1-5. Disponible en: https://doi.org/10.1016/j.tox.2014.02.014
16. Tighe S, Gao Y-Y, Tseng SCG. Terpinen-4-ol is the Most Active Ingredient of Tea Tree Oil to Kill Demodex Mites. Translational Vision Science & Technology [Internet]. 2013;2:2. Disponible en: https://doi.org/10.1167/tvst.2.7.2
17. Navel V, Mulliez A, Benoist d’Azy C, Baker JS, Malecaze J, Chiambaretta F, et al. Efficacy of treatments for Demodex blepharitis: A systematic review and meta-analysis. The Ocular Surface [Internet]. 2019;17:655-69. Disponible en: https://doi.org/10.1016/j.jtos.2019.06.004
18. Drozdova EA, Mikhailova E. Individual Approach to the Treatment of Complicated Forms of Blepharitis: from Theory to Practice. Ophthalmology in Russia [Internet]. 2020;17:830-7. Disponible en: https://doi.org/10.18008/1816-5095-2020-4-830-837
19. Zarei-Ghanavati S, Nooghabi MJ, Zamani G. Comparison of the Effect of Tea Tree Oil Shampoo With Regular Eyelid Shampoo in Meibomian Gland Dysfunction Treatment. American Journal of Ophthalmology [Internet]. 2021;229:45-51. Disponible en: https://doi.org/10.1016/j.ajo.2021.04.009
20. Sabeti S, Kheirkhah A, Yin J, Dana R. Management of meibomian gland dysfunction: a review. Survey of Ophthalmology [Internet]. 2020;65:205-17. Disponible en: https://doi.org/10.1016/j.survophthal.2019.08.007
21. Hassan A, Balal S, Ahmad S. Meibomian gland dysfunction, dropout and distress: emerging therapies. Eye (Basingstoke) [Internet]. 2020;34:1494-6. Disponible en: https://doi.org/10.1038/s41433-020-0865-5
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Zulma Samara Santos Rueda

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
https://orcid.org/0000-0002-3300-314X




